These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 11139409)

  • 1. Evidence about the use of naltrexone and for different ways of using it in the treatment of alcoholism.
    Sinclair JD
    Alcohol Alcohol; 2001; 36(1):2-10. PubMed ID: 11139409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naltrexone: a controversial therapy for alcohol dependence.
    Freed PE; York LN
    J Psychosoc Nurs Ment Health Serv; 1997 Jul; 35(7):24-8. PubMed ID: 9243420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using naltrexone in inpatient alcoholism treatment.
    Knox PC; Donovan DM
    J Psychoactive Drugs; 1999; 31(4):373-88. PubMed ID: 10681104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted nalmefene with simple medical management in the treatment of heavy drinkers: a randomized double-blind placebo-controlled multicenter study.
    Karhuvaara S; Simojoki K; Virta A; Rosberg M; Löyttyniemi E; Nurminen T; Kallio A; Mäkelä R
    Alcohol Clin Exp Res; 2007 Jul; 31(7):1179-87. PubMed ID: 17451401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do acamprosate or naltrexone have an effect on daily drinking by reducing craving for alcohol?
    Richardson K; Baillie A; Reid S; Morley K; Teesson M; Sannibale C; Weltman M; Haber P
    Addiction; 2008 Jun; 103(6):953-9. PubMed ID: 18482418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind, placebo-controlled study of oral nalmefene for alcohol dependence.
    Mason BJ; Salvato FR; Williams LD; Ritvo EC; Cutler RB
    Arch Gen Psychiatry; 1999 Aug; 56(8):719-24. PubMed ID: 10435606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid Receptor Antagonists in the Treatment of Alcoholism.
    Serecigni JG
    Adicciones; 2015 Sep; 27(3):214-30. PubMed ID: 26437315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naltrexone: new preparation. Transient preventive efficacy on alcoholic relapse.
    Prescrire Int; 1999 Feb; 8(39):9-11. PubMed ID: 10557566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Family history of alcoholism influences naltrexone-induced reduction in alcohol drinking.
    Krishnan-Sarin S; Krystal JH; Shi J; Pittman B; O'Malley SS
    Biol Psychiatry; 2007 Sep; 62(6):694-7. PubMed ID: 17336941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking.
    Pettinati HM; O'Brien CP; Rabinowitz AR; Wortman SP; Oslin DW; Kampman KM; Dackis CA
    J Clin Psychopharmacol; 2006 Dec; 26(6):610-25. PubMed ID: 17110818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of efficacy of naltrexone in the prevention of alcohol relapse: results from a German multicenter study.
    Gastpar M; Bonnet U; Böning J; Mann K; Schmidt LG; Soyka M; Wetterling T; Kielstein V; Labriola D; Croop R
    J Clin Psychopharmacol; 2002 Dec; 22(6):592-8. PubMed ID: 12454559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naltrexone in the treatment of alcoholism: a clinical review.
    O'Brien CP; Volpicelli LA; Volpicelli JR
    Alcohol; 1996; 13(1):35-9. PubMed ID: 8837932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of naltrexone and nalmefene on subjective response to alcohol among non-treatment-seeking alcoholics and social drinkers.
    Drobes DJ; Anton RF; Thomas SE; Voronin K
    Alcohol Clin Exp Res; 2004 Sep; 28(9):1362-70. PubMed ID: 15365307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response: a double-blind placebo-controlled study.
    Ray LA; Hutchison KE
    Arch Gen Psychiatry; 2007 Sep; 64(9):1069-77. PubMed ID: 17768272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nalmefene. Alcohol dependence: no advance.
    Prescrire Int; 2014 Jun; 23(150):150-2. PubMed ID: 25121147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical uses of naltrexone: a review of the evidence.
    Modesto-Lowe V; Van Kirk J
    Exp Clin Psychopharmacol; 2002 Aug; 10(3):213-27. PubMed ID: 12233982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors for the efficacy of naltrexone treatment in alcohol dependence: sweet preference.
    Laaksonen E; Lahti J; Sinclair JD; Heinälä P; Alho H
    Alcohol Alcohol; 2011; 46(3):308-11. PubMed ID: 21266377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of extended-release naltrexone in patients with relatively higher severity of alcohol dependence.
    Pettinati HM; Silverman BL; Battisti JJ; Forman R; Schweizer E; Gastfriend DR
    Alcohol Clin Exp Res; 2011 Oct; 35(10):1804-11. PubMed ID: 21575016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drugs to decrease alcohol drinking.
    Sinclair JD
    Ann Med; 1990; 22(5):357-62. PubMed ID: 2291844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naltrexone for the treatment of alcoholism: a meta-analysis of randomized controlled trials.
    Srisurapanont M; Jarusuraisin N
    Int J Neuropsychopharmacol; 2005 Jun; 8(2):267-80. PubMed ID: 15850502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.